abstract |
Reported herein are antibodies that specifically bind to human CD19, wherein the antibodies comprise (a) HVR-H1 comprising the amino acid sequence of SEQ ID NO:03, (b) HVR-H2 comprising the amino acid sequence of SEQ ID NO:11, (c) HVR-H3 comprising the amino acid sequence of SEQ ID NO:05, (d) HVR-L1 comprising the amino acid sequence of SEQ ID NO:40, (e) HVR-L2 comprising the amino acid sequence of SEQ ID NO:07 , and (f) an HVR-L3 comprising the amino acid sequence of SEQ ID NO: 08, and methods of using the same. |